newsfilter
← Latest News
Business Wire·

enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial

enGene Holdings Inc. (NASDAQ:ENGN), a clinical-stage, non-viral genetic medicines company, today announced that it will host a conference call and webcast tomorrow, November 11, 2025, at 8:00 a.m. ET to discuss new